A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 910
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SERMs
Long Form : selective estrogen receptor modulators
No. Year Title Co-occurring Abbreviation
2020 A new immunotherapy schedule in addition to first-line hormone therapy for metastatic breast cancer patients in a state of clinical benefit during hormone therapy. AIs, DFI, HT, OS, PFS
2020 A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation. ERalpha and ERbeta, PCa
2020 Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch. AIs
2020 Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. VTE
2020 Bazedoxifene - a promising brain active SERM that crosses the blood brain barrier and enhances spatial memory. ERE, LC-MS
2020 Distinct Approaches of Raloxifene: Its Far-Reaching Beneficial Effects Implicating the HO-System. HO, RAL
2020 Effect of Osteoporosis Medication on Fracture Healing: An Evidence Based Review. BPs, DRF, SrR, TPTD
2020 Estrogen regulates aquaporin-2 expression in the kidney. AQP2
2020 Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles. BMD, VVA
10  2020 Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism? AIs, AR, HH
11  2020 Notch Signaling Pathway and Endocrine Resistance in Breast Cancer. AIs, CSC, ER, SERDs
12  2020 Perioperative Use of Antiestrogen Therapies in Breast Reconstruction: A Systematic Review and Treatment Recommendations. AIs
13  2020 Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease. ER, PD, PDE5is, TA, TGF-beta1
14  2020 Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status. AI, DFS, mTOR, pS6K1
15  2020 Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer. ---
16  2020 Selective estrogen receptor modulators (SERMS): keys to understanding their function. ---
17  2020 Selective Estrogen Receptor Modulators (SERMs): Mechanistic Insights Against Microbial Infections. ---
18  2020 Sexual dimorphism in the microbiology of the CF 'Gender Gap': Estrogen modulation of Pseudomonas aeruginosa virulence. ---
19  2020 Soy isoflavones ameliorate experimental colitis by targeting ERalpha/NLRP3 inflammasome pathways. DSS, ERalpha, SIFs
20  2020 The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor. ---
21  2020 The effect of oestrogen on mandibular condylar cartilage via hypoxia-inducible factor-2alpha during osteoarthritis development. ERbeta, HIF2alpha, OA, TMJ-OA, UAC
22  2020 The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. GSM, QOL
23  2020 The Impact of Estrogen Receptor in Arterial and Lymphatic Vascular Diseases. ER, MISS
24  2020 The role of hormone stimulation in men with non-obstructive azoospermia undergoing surgical sperm retrieval. mTESE, NOA
25  2020 Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor alpha antagonism. ERalpha, HRR, OBHS, Pol II
26  2019 Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models. PD, PDE5i
27  2019 Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism? AIs, BMD, TRT
28  2019 Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care. ---
29  2019 Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators. BZA, CEE
30  2019 Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. ---
31  2019 Breast cancer prevention in high-risk women. AIs, BRRM
32  2019 Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent. AIs, TE
33  2019 Characteristics of adverse events of endocrine therapies among older patients with breast cancer. AIs
34  2019 Dual targeting of estrogen receptor alpha and estrogen-related receptor alpha: a novel endocrine therapy for endometrial cancer. EC, ERalpha, ERRalpha, RAL, TAM
35  2019 EAA clinical practice guidelines-gynecomastia evaluation and management. AFP, AIs, FSH, GM, GRADE, hCG, LH, SHBG, TSH
36  2019 Effects of anti-estrogens on cell invasion and survival in pituitary adenoma cells: A systematic study. ---
37  2019 Effects of the selective estrogen receptor modulators for the treatment of male infertility: a systematic review and meta-analysis. ---
38  2019 Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism. ---
39  2019 Estrogen Receptor alpha (ERalpha)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity. AIs, ERalpha, SERDs
40  2019 Estrogen signaling: An emanating therapeutic target for breast cancer treatment. ER, SERDs
41  2019 Estrogens and SERMS as adjunctive treatments for schizophrenia. ---
42  2019 Future Aspects for Cannabinoids in Breast Cancer Therapy. CB-Rs, CBD, CBs, THC
43  2019 Gonadal Hormones and Bone. AR, ER, SARMs
44  2019 Identification of 10-dehydrooxyglycyuralin E as a selective human estrogen receptor alpha partial agonist. ER
45  2019 In silico study of molecular mechanisms of action: Estrogenic disruptors among phthalate esters. AF-2, ERs, hERalpha, PAEs
46  2019 In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues. AOX1, SERM
47  2019 Influence of Supplementary Vitamin D on Bone Mineral Density When Used in Combination with Selective Estrogen Receptor Modulators. BMD
48  2019 Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. PTH, TSECs
49  2019 MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators. miR-27a
50  2019 Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index. NO-SERMs
51  2019 Osteoporosis: long-term treatment versus drug holiday-what is the evidence? ASBMR, ECTS
52  2019 Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site. ---
53  2019 Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis. ADT, BMD, CI, PCa
54  2019 Raloxifene recovers effects of prenatal immune activation on cognitive task-induced gamma power. ---
55  2019 Synthesis and characterization of hydrogen peroxide activated estrogen receptor beta ligands. DPN, ERbeta, ROS
56  2019 Synthesis of a benzoxazinthione derivative of tanaproget and pharmacological evaluation for PET imaging of PR expression. ER, PET, PR, RCP
57  2019 The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women. BP, MHS, PDC
58  2019 The Prevention and Therapy of Osteoporosis: A Review on Emerging Trends from Hormonal Therapy to Synthetic Drugs to Plant-Based Bioactives. SR
59  2019 The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics. AD, ALS, CNS, EAAT1, GLAST, GLT-1, HDACi, PD
60  2019 The selective estrogen receptor modulator raloxifene mitigates the effect of all-trans-retinal toxicity in photoreceptor degeneration. 11-cisRAL, AMD, atRAL, RP
61  2019 The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture. ER, UWCCC
62  2019 The use of selective estrogen receptor modulators on bone health in men. BMD
63  2019 Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor alpha Ligand Binding Domain. ERalpha, LBD
64  2019 Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha. SERDs
65  2019 Uterine Malignant Mixed Mullerian Tumors Following Treatment with Selective Estrogen Receptor Modulators in Patients with Breast Cancer: A Report of 13 Cases and Their Clinicopathologic Characteristics. ER, S-uMMMTs, uMMMTs
66  2018 27-Hydroxycholesterol Is an Estrogen Receptor beta-Selective Negative Allosteric Modifier of 17beta-Estradiol Binding. ER
67  2018 Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ERalpha and PPAR-gamma. ERs
68  2018 Chemoprevention: A new concept for cancer prevention in primary care ---
69  2018 Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. SHR, SR
70  2018 Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-alpha). ERalpha
71  2018 Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators. BC
72  2018 Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model. ---
73  2018 Effects of Toremifene, a Selective Estrogen Receptor Modulator, on Spontaneous and Stimulated GH Secretion, IGF-I, and IGF-Binding Proteins in Healthy Elderly Subjects. GH, IGF, IGFBP, SHBG
74  2018 Estrogenic properties of coumarins and meroterpene from the fruits of Cullen corylifolium: Experimental and computational studies. CSEV, ERE-Luc, FP, hERalpha, hERalpha-LBD
75  2018 Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells. ALP, LAS, RAL
76  2018 Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer. AF1, ER, FBXO22, HER2-negative, SRC, TAM-bound
77  2018 Genistein Improves Skin Flap Viability in Rats: A Preliminary In Vivo and In Vitro Investigation. ---
78  2018 Hormonal Therapy Resistant Estrogen-receptor Positive Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment Selection in Japan. AI, ET, HORSE-BC, MBC, mTOR
79  2018 Identification of Estrogen Receptor alpha Antagonists from Natural Products via In Vitro and In Silico Approaches. ERalpha
80  2018 Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer. 5-FU, BC, lncRNAs, ROR, UCA1
81  2018 miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22. GO, miRNAs, qRT-PCR
82  2018 New approach based on immunochemical techniques for monitoring of selective estrogen receptor modulators (SERMs) in human urine. HTS, TDM, WADA
83  2018 Nonsteroidal estrogen receptor isoform-selective biphenyls. ER, MD, MM-GBSA, TAM
84  2018 Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene. ALP, ERalpha, ERbeta, OBs, Pyk2
85  2018 Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. SERDs
86  2018 SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells. ER
87  2018 Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor. ER
88  2018 Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives. ---
89  2018 The guiding role of bone metabolism test in osteoporosis treatment. OP
90  2018 The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects. ERs, NO
91  2018 Tissue selective estrogen complex (TSEC): a review. TSEC
92  2018 Towards optimization of estrogen receptor modulation in medicine. AF, ER, MHT
93  2018 Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation. AFM, FESEM, HRTEM, XRD
94  2018 Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders. ---
95  2018 ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer. BC, SNPs
96  2018 [Towards an optimization of the modulation of the estrogen receptor during menopausal hormonal therapy]. ERalpha, MHT
97  2017 "Cherchez La Femme": Modulation of Estrogen Receptor Function With Selective Modulators: Clinical Implications in the Field of Urology. ---
98  2017 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator. 27HC, ERs
99  2017 Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERalpha metastatic breast cancer. AIs
100  2017 ADJUVANT (HORMONAL) THERAPY AS A CAUSE OF BONE LOSS IN PATIENTS WITH BREAST CANCER (REVIEW OF LITERATURE). BMD, DXA